Among these client proteins are steroid hormone receptors for estrogen and progesterone, receptor tyrosine kinases (e.g., HER2), epidermal growth factor receptor (EGFR) and intermediates of oncogenic signaling cascades (AKT and RAF1) relevant to various breast cancer subtypes3. This evidence concerns the gene EGFR and breast cancer.